AC
EXAS

Avestar Capital’s Exact Sciences EXAS Stock Holding History

Avestar Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50
Closed -$5K – 392
2019
Q2 		$5K Hold
50
– – ﹤0.01% 578
2019
Q1 		$4K Hold
50
– – ﹤0.01% 589
2018
Q4 		$3K Hold
50
– – ﹤0.01% 587
2018
Q3 		$3K Hold
50
– – ﹤0.01% 594
2018
Q2 		$2K Hold
50
– – ﹤0.01% 674
2018
Q1 		$2K Hold
50
– – ﹤0.01% 633
2017
Q4 		$2K Buy
+50
New +$2.67K ﹤0.01% 626

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Avestar Capital's EXAS Position: Q3 2019 in Review

Avestar Capital sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 50 shares — an estimated $5K sold.

Avestar Capital first reported a position in EXAS in Q4 2017 and held it in 7 quarters. The position peaked at $5K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Avestar Capital reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Avestar Capital sold 50 Exact Sciences shares in Q3 2019, an estimated $5K.
  • Avestar Capital first reported a position in Exact Sciences in Q4 2017 and held it in 7 quarters.
  • Avestar Capital's Exact Sciences position peaked at $5K in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.